In- and out-licensing

In Out licensing Agency Consulting firm Experts Specialists Consultancy

Find the right partners to add value to your products or acquire licenses

For more than 30 years, our specialized team has been supporting companies in the health industry in their projects for developing and exploiting licenses, and more particularly in the partner search for in and out licensing.

    Tell us about your uncharted territory

    You have a project and want to discuss it with our explorers, write us!

    One of our explorers will contact you shortly.


    They trust us

    Logo_carre_APHP
    Logo_carre_Bayer
    Logo_carre_Boehringer_Ingelheim
    Logo_carre_Grand_Lyon
    Logo_carre_J&J
    Logo_carre_Loreal
    Logo_carre_Mars
    logo_carre_michelin
    Logo_carre_Moderna
    Logo_carre_Nesle
    Logo_carre_reseau_SATT
    Logo_carre_Roche
    Logo_carre_Saint_Gobin
    Logo_carre_Sanofi
    Logo_carre_Solvay
    Logo_carre_Suez
    Logo_carre_Thales

    The challenges related to in and out licensing

    The emerging trend of in- and out-licensing in the health industry is motivated by several factors, including the increased costs and risks associated with developing a new medication or new technology, the lack of internal expertise, and the need to enlarge ones portfolio of patents and products.

    In- and out-licensing offers opportunities to biotechs and pharmas to access new technologies and products or new markets, all while reducing the associated financial and organizational risks, in order to remain competitive in constantly evolving industries.

    In order to maximize the potential of in- and out-licensing, it is important to bring attention to the associated challenges, in particular:

    For in licensing

    For out-licensing

      Tell us about your uncharted territory

      You have a project and want to discuss it with our explorers, write us!

      One of our explorers will contact you shortly.


      How we support you in your in and out licensing projects

      For more than 30 years, Alcimed has been supporting clients in their innovation and development projects relating to acquiring and granting licenses.

      The diversity of our clients (large industry players, biotechs, SMEs, start-ups), the geographic fields and therapeutic areas we explore, and the types of projects we carry out give us a global and in-depth understanding of the challenges of in- and out-licensing projects.

      From the elaboration of license-granting strategies to the identification of potential partners, we provide a strategic and operational support to our clients. Our investigational and analytical capacities put at the disposition of our clients all of the necessary information for decision making in the framework of their in- or out-licensing strategy.

      Examples of recent in in and out licensing projects carried out for our clients

      • Strategic evaluation of an in-licensing opportunity in the pain management market

        We supported a pharmaceutical player in the evaluation of an in-licensing opportunity for a digital pain support product.

        We characterized the key markets in pain management by segmenting them per geographic zone and by usage case, and we evaluated the potential of the solutions by taking into account specificities, regulations, market access, cultural habits, and more.

        In the end, we validated the value proposition of the start-up and recommended to our client to proceed with due diligence.

      • Partner search for in-licensing connected technologies for a medical device player

        For a healthcare industry client, we identified a product that involved connected technologies adaptable to medical gas bottles in order to promote the optimization of logistical flows and propose new services, such as monitoring patient physiological parameters.

        After precisely defining with the client the filtering criteria of technologies to explore (maturity, price, competitive intensity, operating freedom, etc.), our team carried out a primary selection of pertinent technologies for our client’s product. Then, after having defined and chosen a more fine-combed selection, we analyzed for each technology the type of data that could be generated, their value and their limits (connectivity, long-distance communication, autonomy, etc.).

        In the end, we recommended three key technologies for our client’s product and we introduced them to the developers of these technologies to establish a licensing agreement partnership.

      • Evaluating licensing opportunities in e-Health

        We supported one of our clients, a leading healthcare industry player, in the evaluation of a strategic opportunity in the e-Health speech disorders market. To do so, our team conducted a landscaping investigation to identify the players, and to understand and evaluate the tele-therapy market for speech and language disorders. We interviewed potential partners to understand their solutions and their current business models, and to consider a product licensing partnership with our client. For this partner search, our team developed a visualization tool which showed in an interactive manner the potential partnership between our client and each of the studied companies. In the end our client could short-list partners, meet them, and conclude a licensing deal with one of them for their product.

      • Search for a pharma licensing partners

        We supported a major industrial player in the identification of targeting companies with which to establish in-/out-licensing partnerships. Our client had a well-established sales force in several geographies across the world, and was interested in partners with products that were already in advanced stages of development or market access, or that were already on the market.

        Our client’s New Business Development team was lacking information regarding the strategy and needs of medium-sized pharma companies in terms of product partnerships. To this end, our team analyzed around a hundred companies according to diverse criteria established by our client (such as therapeutic areas of interest, geographic overlap with our client, product types, level of R&D advancement, market access phase, etc.) before establishing a shortlist of 30 companies to characterize in more depth.

        We then exchanged with teams of the selected targets to understand their needs and expectations in terms of licensing, to underline the potential of out-licensing with them, and to present the main points of the partnership proposed by our client.

        In the end, the New Business Development team of our client could contact the targets who had expressed a first level of interest, all while refining their commercial approach based on the results of our study.

      You have a project?

        Tell us about your uncharted territory

        You have a project and want to discuss it with our explorers, write us!

        One of our explorers will contact you shortly.